John Quisel
Chief Executive Officer bei DISC MEDICINE, INC.
Vermögen: 4 Mio $ am 31.03.2024
Profil
John D.
Quisel is currently serving as the President, Chief Executive Officer & Director at Disc Medicine Opco, Inc. and Disc Medicine, Inc. He is also an Independent Director at Gossamer Bio, Inc. Additionally, he serves as an Advisor at Atlas Venture Advisors, Inc. Previously, Dr. Quisel held positions as the Chief Executive Officer & Director at Gemini Therapeutics, Inc. He also served as the Secretary & Senior VP-Corporate Development at Acceleron Pharma, Inc. from 2006 to 2018.
Prior to that, he worked as an Attorney at Foley Hoag LLP and as an Associate at Ropes & Gray LLP.
Dr. Quisel completed his undergraduate studies at Harvard University in 1993.
He then pursued his graduate degree at Stanford University in 1996 and obtained a doctorate from the Massachusetts Institute of Technology in 2000.
He later earned a graduate degree from Harvard Law School in 2004 and completed his undergraduate degree at Harvard College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
DISC MEDICINE, INC.
0,28% | 10.01.2024 | 69 065 ( 0,28% ) | 4 Mio $ | 31.03.2024 |
Aktive Positionen von John Quisel
| Unternehmen | Position | Beginn |
|---|---|---|
| DISC MEDICINE, INC. | Chief Executive Officer | 29.12.2022 |
| GOSSAMER BIO, INC. | Director/Board Member | 28.11.2023 |
Disc Medicine Opco, Inc.
 Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Chief Executive Officer | 25.02.2020 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | - |
Ehemalige bekannte Positionen von John Quisel
| Unternehmen | Position | Ende |
|---|---|---|
| ACCELERON PHARMA INC. | Corporate Officer/Principal | 24.02.2020 |
| GEMI THER | Chief Executive Officer | - |
Ropes & Gray LLP
 Ropes & Gray LLP Miscellaneous Commercial ServicesCommercial Services Ropes & Gray LLP provides legal and private equity services. Its practice areas include asset management, banking, business and commercial litigation, business restructuring, capital markets and corporate governance and compliance. The company was founded in 1865 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Foley Hoag LLP
 Foley Hoag LLP Miscellaneous Commercial ServicesCommercial Services Foley Hoag LLP provides legal services. It offers international litigation and arbitration services, and counsel in the evolving field of corporate social responsibility. The firm offers practices in industries such as life sciences, health care, technology, energy and renewable, investment management, and professional services. The company was founded in 1943 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Ausbildung von John Quisel
| Harvard University | Undergraduate Degree |
| Stanford University | Graduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
| Harvard Law School | Graduate Degree |
| Harvard College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GOSSAMER BIO, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Foley Hoag LLP
Foley Hoag LLP Miscellaneous Commercial ServicesCommercial Services Foley Hoag LLP provides legal services. It offers international litigation and arbitration services, and counsel in the evolving field of corporate social responsibility. The firm offers practices in industries such as life sciences, health care, technology, energy and renewable, investment management, and professional services. The company was founded in 1943 and is headquartered in Boston, MA. | Commercial Services |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Ropes & Gray LLP
Ropes & Gray LLP Miscellaneous Commercial ServicesCommercial Services Ropes & Gray LLP provides legal and private equity services. Its practice areas include asset management, banking, business and commercial litigation, business restructuring, capital markets and corporate governance and compliance. The company was founded in 1865 and is headquartered in Boston, MA. | Commercial Services |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Health Technology |
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration. The company was founded by Johanna Seddon, Paul Barlow and Andrew Herbert on March 3, 2015 and is headquartered in Cambridge, MA. | Health Technology |
| Disc Medicine, Inc. |
